Browsing by Author "Chuang, Yung-Jen"
Now showing 1 - 3 of 3
- Results Per Page
- Sort Options
Item type:Item, Confocal Imaging Guided Photochemical Thrombosis Toward the Development of a Novel Zebrafish Model of Stroke(2016-01-01) ;Lee, I-Ju ;Hsu, Jia-Wen ;Chuang, Yung-Jen ;Liau, Ian生物科技學系Confocal imaging guided photochemical thrombosis was demonstrated on living zebrafish. Occlusion at selected cerebral blood vessels caused varied mortality rate and neurological outcome. This novel zebrafish stroke model may facilitate translational research and thrombolytic screening.Item type:Item, Extension of C-elegans lifespan using the center dot NO-delivery dinitrosyl iron complexes(2018-07-01) ;Huang, Hsiao-Wen ;Lin, Yen-Hung ;Lin, Min-Hsuan ;Huang, Ya-RongChou, Chih-HungThe ubiquitous and emerging physiology function of endogenous nitric oxide in vascular, myocardial, immune, and neuronal systems prompts chemists to develop a prodrug for the controlled delivery of center dot NO in vivo and for the translational biomedical application. Inspired by the discovery of natural [Fe(NO)(2)] motif, herein, we develop the synthetic dinitrosyl iron complexes (DNICs) [Fe-2(mu-SR)(2)(NO)(4)] (1) as a universal platform for the O-2-triggered release of center dot NO, for the regulation of center dot NO-release kinetics (half-life = 0.6-27.4 h), and for the activation of physiological function of center dot NO. Using C. elegans as a model organism, the center dot NO-delivery DNIC 1 regulates IIS signaling pathway, AMPK signaling pathway, and mitochondrial function pathway to extend the lifespan and to delay the aging process based on the lifespan analysis, SA-beta gal activity assay, and next-generation RNA sequencing analysis. This study unveils the anti-aging effect of center dot NO and develops DNICs as a chemical biology probe for the continued discovery of unprecedented NO physiology. [GRAPHICS] .Item type:Item, Zebrafish model of photochemical thrombosis for translational research and thrombolytic screening in vivo(2017-04-01) ;Lee, I-Ju ;Yang, Yi-Cyun ;Hsu, Jia-Wen ;Chang, Wei-TienChuang, Yung-JenAcute thromboembolic diseases remain the major global cause of death or disability. Although an array of thrombolytic and antithrombotic drugs has been approved to treat or prevent thromboembolic diseases, many more drugs that target specific clotting mechanisms are under development. Here a novel zebrafish model of photochemical thrombosis is reported and its prospective application for the screening and preclinical testing of thrombolytic agents in vivo is demonstrated. Through photochemical excitation, a thrombus was induced to form at a selected section of the dorsal aorta of larval zebrafish, which had been injected with photosensitizers. Such photochemical thrombosis can be consistently controlled to occlude partially or completely the targeted blood vessel. Detailed mechanistic tests indicate that the zebrafish model of photochemical thrombosis exhibits essential features of classical coagulation and a thrombolytic pathway. For demonstration, tissue plasminogen activator (tPA), a clinically feasible thrombolytic agent, was shown to effectively dissolve photochemically induced blood clots. In light of the numerous unique advantages of zebrafish as a model organism, our approach is expected to benefit not only the development of novel thrombolytic and antithrombotic strategies but also the fundamental or translational research targeting hereditary thrombotic or coagulation disorders.